Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Pathobiology of cast nephropathy from human Bence Jones proteins.
P W Sanders, B B Booker
P W Sanders, B B Booker
Published February 1, 1992
Citation Information: J Clin Invest. 1992;89(2):630-639. https://doi.org/10.1172/JCI115629.
View: Text | PDF
Research Article Article has an altmetric score of 9

Pathobiology of cast nephropathy from human Bence Jones proteins.

  • Text
  • PDF
Abstract

Renal failure is a common accompaniment of multiple myeloma and is usually due to cast nephropathy, or "myeloma kidney." To understand this lesion, four human Bence Jones proteins (BJP) were purified from the urine of volunteers who had either no evidence of renal dysfunction (BJP1) or renal failure from cast nephropathy (BJP2, BJP3, BJP4). When infused directly into the rat nephron in vivo, BJP2, BJP3, and BJP4 produced intraluminal obstruction by precipitating in the distal nephron; protein casts were never identified before the tip of the loop of Henle. Obstruction was related to the concentration of BJP in the perfusate. Addition of furosemide to the perfusate augmented obstruction in a concentration-dependent fashion. Pretreatment of rats with colchicine completely prevented obstruction and cast formation of perfused nephrons; beta-lumicolchicine did not prevent obstruction. Tamm-Horsfall glycoprotein purified from beta-lumicolchicine-treated and untreated rats coaggregated with BJP3 in vitro. Tamm-Horsfall glycoprotein from colchicine-treated rats did not contain sialic acid and did not aggregate with BJP3 in vitro. Thus, cast-forming human BJP coaggregated with Tamm-Horsfall glycoprotein and obstructed the rat distal nephron. Intranephronal obstruction was aggravated by decreasing extracellular fluid volume or adding furosemide. Finally, by decreasing secretion and altering the carbohydrate moiety of Tamm-Horsfall glycoprotein, colchicine prevented intraluminal cast formation and obstruction of the rat nephron.

Authors

P W Sanders, B B Booker

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1995 1994 1993 1992 1987 Total
Citations: 1 6 3 6 9 5 7 9 4 5 8 3 17 10 3 1 11 3 2 1 2 2 2 4 2 4 5 4 3 4 1 1 148
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (148)

Title and authors Publication Year
Monoclonal gammopathy of renal significance from the perspective of nephrologists.
Park K, Kwon SH
Blood Research 2024
Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chains.
Sternke-Hoffmann R, Pauly T, Norrild RK, Hansen J, Tucholski F, Høie MH, Marcatili P, Dupré M, Duchateau M, Rey M, Malosse C, Metzger S, Boquoi A, Platten F, Egelhaaf SU, Chamot-Rooke J, Fenk R, Nagel-Steger L, Haas R, Buell AK
BMC Biology 2023
Multiple myeloma with acute light chain cast nephropathy.
Leung N, Rajkumar SV
Blood Cancer Journal 2023
High-Cutoff Hemodialysis Therapy for Patients with Light Chain Cast Nephropathy and AKI Requiring Dialysis: CON.
Karakala N, Juncos LA
2023
Extracorporeal light-chain elimination in myeloma with simple medium cutoff membrane hemodialysis: a retrospective cohort study.
Schaaf CW, Braunisch MC, Holzmann-Littig C, Pfister F, Hannemann L, Hausinger RI, Verbeek M, Schmaderer C, Renders L, Heemann U, Küchle C
Frontiers in Oncology 2023
Epigenetic roles in clonal hematopoiesis and aging kidney-related chronic kidney disease.
Ogura Y, Mimura I
Frontiers in Cell and Developmental Biology 2023
How I Treat Light Chain Cast Nephropathy
Pratt G, Pinney JH, Cockwell P
Clinical journal of the American Society of Nephrology : CJASN 2023
Rhabdomyolysis: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document.
Kodadek L, Carmichael Ii SP, Seshadri A, Pathak A, Hoth J, Appelbaum R, Michetti CP, Gonzalez RP
2022
Diagnosis and management of monoclonal gammopathy of clinical significance.
Cho H
Blood Research 2022
High-cutoff hemodialysis in multiple myeloma patients with acute kidney injury.
Xing Y, Yan J, Yu Z, Zhao J, Wang Y, Li X, Qin Y, Sun S
Frontiers in Oncology 2022
Management of acute kidney injury in symptomatic multiple myeloma
F Bridoux, N Leung, M Belmouaz, V Royal, P Ronco, SH Nasr, JP Fermand
Kidney International 2021
The Clone Wars: Diagnosing and Treating Dysproteinemic Kidney Disease in the Modern Era
RS Avasare, NK Andeen, A Havasi, JJ Hogan
Journal of Clinical Medicine 2021
Kidney injury and disease in patients with haematological malignancies
F Bridoux, P Cockwell, I Glezerman, V Gutgarts, JJ Hogan, KD Jhaveri, F Joly, SH Nasr, D Sawinski, N Leung
Nature Reviews Nephrology 2021
Management of Bone Disease and Kidney Failure in Multiple Myeloma: A Pocket Guide
E Zamagni
2021
Acute Kidney Injury in Monoclonal Gammopathies
P Menè, A Moioli, A Stoppacciaro, S Lai, F Festuccia
Journal of Clinical Medicine 2021
De Novo Sequencing of Antibody Light Chain Proteoforms from Patients with Multiple Myeloma
M Dupré, M Duchateau, R Sternke-Hoffmann, A Boquoi, C Malosse, R Fenk, R Haas, AK Buell, M Rey, J Chamot-Rooke
Analytical Chemistry 2021
Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study
P Yadav, IJ Sathick, N Leung, EE Brown, M Cook, PW Sanders, P Cockwell
Blood Cancer Journal 2020
Hemodiafiltration with ultrafiltrate regeneration reduces free light chains without albumin loss in multiple myeloma patients
MV de Mier, R Ojeda, MA Álvarez-Lara, A Navas, C Alonso, J Caballero-Villarraso, P Aljama, MA Álvarez, S Soriano, M Rodríguez, A Martín-Malo
BMC Nephrology 2020
Biochemical and biophysical characterisation of immunoglobulin free light chains derived from an initially unbiased population of patients with light chain disease
R Sternke-Hoffmann, A Boquoi, DL Niedenhoff, F Platten, R Fenk, R Haas, AK Buell
PeerJ 2020
Monoclonal Gammopathies of Renal Significance: Renal Biopsy and Beyond
P Menè, LD Alexandris, A Moioli, S Raffa, A Stoppacciaro
Cancers 2020
Uromodulin and kidneys
M Khasun, SA Orlova, IG Kayukov, OV Galkina, ON Beresneva, MM Parastaeva, AG Kucher, NV Mosina
2020
Onconephrology: The intersections between the kidney and cancer
MH Rosner, KD Jhaveri, BA McMahon, MA Perazella
CA: a cancer journal for clinicians 2020
Fatal renal diseases among patients with hematological malignancies: A population‐based study
S Li, K Yu, Y Chen, W Luo, Y Zheng, Y Yang, X Yang, , X Gao, X Wang, B Wu
2020
Predictive factors of outcome in cervical dystonia following deep brain stimulation: an individual patient data meta-analysis
X Hua, B Zhang, Z Zheng, H Fan, L Luo, X Chen, J Duan, D Zhou, M Li, T Hong, G Lu
Journal of Neurology 2020
Fatal renal diseases among patients with hematological malignancies: A population-based study.
Li S, Yu K, Chen Y, Luo W, Zheng Y, Yang Y, Yang X, Wang X, Gao X, Wang X, Wu B
2020
The Role of Volume Regulation and Thermoregulation in AKI during Marathon Running
SG Mansour, TG Martin, W Obeid, RW Pata, KM Myrick, L Kukova, Y Jia, P Bjornstad, JM El-Khoury, CR Parikh
Clinical journal of the American Society of Nephrology : CJASN 2019
Activin A: a novel urinary biomarker of renal impairment in multiple myeloma
H Iriuchishima, A Maeshima, S Takahashi, T Ishizaki, A Yokohama, N Tsukamoto, T Saitoh, H Murakami, H Handa
Bioscience Reports 2019
Acute kidney injury in the patient with cancer
MH Rosner, MA Perazella
Kidney Research and Clinical Practice 2019
A rare case of crystalglobulinemia
B Prasad, R Chibbar, S Muhammad, S Sethi
2019
CLINICAL IMPORTANCE OF RENAL RECOVER ON OUTCOMES OF NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH SEVERE AND DIALYSIS-DEPENDENT KIDNEY FAILURE
SV Semochkin, EI Zhelnova, EN Misyurina, DS Maryin, AI Ushakova, EA Karimova, EA Baryakh, TN Tolstykh, ES Mavrina, EV Yurova, AV Cherkasova, EY Grishina, DE Gagloeva, KV Yatskov, ON Kotenko, MA Lysenko
2019
Animal models of monoclonal immunoglobulin-related renal diseases
C Sirac, GA Herrera, PW Sanders, V Batuman, S Bender, MV Ayala, V Javaugue, J Teng, EA Turbat-Herrera, M Cogné, G Touchard, N Leung, F Bridoux
Nature Reviews Nephrology 2018
Myeloma light chain cast nephropathy, a review
IJ Sathick, ME Drosou, N Leung
Journal of Nephrology 2018
Light Chain Cast Nephropathy: Practical Considerations in the Management of Myeloma Kidney—What We Know and What the Future May Hold
S Manohar, SH Nasr, N Leung
Current Hematologic Malignancy Reports 2018
Dystonia
B Balint, NE Mencacci, EM Valente, A Pisani, J Rothwell, J Jankovic, M Vidailhet, KP Bhatia
Nature Reviews Disease Primers 2018
Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma
P Yadav, P Cockwell, M Cook, J Pinney, H Giles, YS Aung, D Cairns, RG Owen, FE Davies, GH Jackson, JA Child, GJ Morgan, MT Drayson
BMC Nephrology 2018
A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease
SH Nielsen, DG Rasmussen, S Brix, A Fenton, M Jesky, CJ Ferro, M Karsdal, F Genovese, P Cockwell, AI Aguilera
PloS one 2018
κ Light-chain monoclonal gammopathy and cast nephropathy in a horse with multiple myeloma
C Eberhardt, A Malbon, B Riond, A Schoster
Journal of the American Veterinary Medical Association 2018
Uromodulin: from physiology to rare and complex kidney disorders
O Devuyst, E Olinger, L Rampoldi
Nature Reviews Nephrology 2017
Bicarbonate : de la physiologie aux applications thérapeutiques pour tout clinicien
J Beaume, A Braconnier, T Dolley-Hitze, JP Bertocchio
Néphrologie & Thérapeutique 2017
Insuffisance rénale aiguë obstructive : une lecture physiopathologique
JP Haymann, C Vinsonneau, A Girshovich, M Daudon
Néphrologie & Thérapeutique 2017
Acute Kidney Injury in Patients with Cancer
JR Ingelfinger, MH Rosner, MA Perazella
New England Journal of Medicine 2017
The Scope of Kidney Affection in Monoclonal Gammopathies at All Levels of Clinical Significance
ŞM Ünlü, H Özsan, S Sarıoğlu
Turkish Journal of Hematology 2017
Dysproteinemias and Glomerular Disease
N Leung, ME Drosou, SH Nasr
Clinical journal of the American Society of Nephrology : CJASN 2017
Neoplastic Diseases of the Blood
PH Wiernik, JP Dutcher, MA Gertz
2017
My Patient with Monoclonal Gammopathy of Undetermined Significance has a Kidney Problem
N Leung
2017
AKI in Multiple Myeloma: Paraproteins, Metabolic Disturbances, and Drug Toxicity
M Shah, MA Perazella
2017
Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins--What Determines the Site of Injury?
M Doshi, A Lahoti, FR Danesh, V Batuman, PW Sanders
Clinical journal of the American Society of Nephrology : CJASN 2016
Non-Secretory Myeloma, Diagnosed on Renal Biopsy as Cast Nephropathy
S Grover
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH 2016
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, H Goldschmidt, D Joshua, RZ Orlowski, R Powles, DH Vesole, L Garderet, H Einsele, A Palumbo, M Cavo, PG Richardson, P Moreau, JS Miguel, SV Rajkumar, BG Durie, E Terpos
Journal of Clinical Oncology 2016
Plasma Cell Neoplasms
RB Lorsbach, M Yared
2016
Circulating Monoclonal Light Chains and Acute Kidney Injury: The Role of the Renal Biopsy with Emphasis on Ultrastructural Evaluation in Assessing and Understanding Renal Injury
J Aufman, GA Herrera
Ultrastructural Pathology 2015
High incidence of intact immunoglobulin or fragments thereof in urine of patients with multiple myeloma
M Kraj, B Kruk, E Lech-Marańda, K Warzocha, M Prochorec-Sobieszek
Leukemia & Lymphoma 2015
New aspects on the pathogenesis of renal disorders related to monoclonal gammopathies
S Kapoulas, V Raptis, M Papaioanou
Néphrologie & Thérapeutique 2015
Renal Consequences of Lymphoproliferative Disorders and Monoclonal Gammopathy
EV Zakharova
2015
Onconephrology
KD Jhaveri, AK Salahudeen
2015
Pathogenesis of Renal Failure in Multiple Myeloma: Any Role of Contrast Media?
M Mussap, G Merlini
BioMed Research International 2014
Renal disease in cancer patients
JR Angelo, JA Samuels
Renal disease in cancer patients 2014
Case report on renal failure reversal in lambda chain multiple myeloma with bortezomib and dexamethasone
BK Patibandla, A Narra, AA Alwassia, A Bartley, GS Sandhu, J Rooney, RM Black
Case Reports in Nephrology 2014
Clearance of Drugs for Multiple Myeloma Therapy During In Vitro High-Cutoff Hemodialysis: Thoughts and Progress
DH Krieter, E Devine, C Wanner, M Storr, B Krause, HD Lemke
Artificial Organs 2014
Manifestations rénales au cours du myélome
N Bennani-Guebessi, C Ahomadegbe, S Zamiati
Journal Africain du Cancer / African Journal of Cancer 2014
Exploring the Relationship Between Serum and Urinary Free Light Chain Levels During the Different Phases of Renal Damage in Multiple Myeloma Patients
ZL Xu, C Wu, WH Teng, K Wan, WJ Jia, HJ Li, L Meng, JF Zhou, Y Tang
Indian Journal of Hematology and Blood Transfusion 2014
Multiple myeloma
GR Mehta, F Suhail, RY Haddad, G Zalzaleh, EV Lerma
Disease-a-Month 2014
Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma
L Hobeika, SE Self, JC Velez
BMC Nephrology 2014
Predictors of Positive Immunofixation Testing in Patients With Acute Kidney Injury:
J Mattana, V Govindappa, A Adamidis, N Kohn
The American Journal of the Medical Sciences 2013
Current treatments for renal failure due to multiple myeloma
E Kastritis, E Terpos, MA Dimopoulos
Expert Opinion on Pharmacotherapy 2013
Tubulopathie myélomateuse : l’espoir d’un nouveau médicament
SA el Haj, A Hertig
Néphrologie & Thérapeutique 2013
Mechanism and Prevention of Acute Kidney Injury from Cast Nephropathy in a Rodent Model
Wei-Zhong Ying, Christopher Allen, Lisa Curtis, Kristal Aaron, Paul W. Sanders
Journal of Clinical Investigation 2012
Treating myeloma cast nephropathy without treating the myeloma
Nelson Leung
Journal of Clinical Investigation 2012
Uromodulin in Kidney Injury: An Instigator, Bystander, or Protector?
TM El-Achkar, XR Wu
American Journal of Kidney Diseases 2012
Novel approaches for reducing free light chains in patients with myeloma kidney
CA Hutchison, J Bladé, P Cockwell, M Cook, M Drayson, JP Fermand, E Kastritis, R Kyle, N Leung, S Pasquali, C Winearls
Nature Reviews Nephrology 2012
Screening and Differential Diagnosis of Renal Light Chain-Associated Diseases
J Gerth, A Sachse, M Busch, N Illner, LO Muegge, HJ Gröne, G Wolf
Kidney & blood pressure research 2012
Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis
CA Hutchison, N Heyne, P Airia, R Schindler, D Zickler, M Cook, P Cockwell, D Grima
Nephrology Dialysis Transplantation 2012
Dysproteinemias or light chain diseases
AB Irish, R Sinniah
Nephrology Secrets 2012
Successful Treatment of Patients With Multiple Myeloma and Impaired Renal Function With Lenalidomide: Results of 4 German Centers
K Oehrlein, C Langer, I Sturm, W Pönisch, C Hahn-Ast, S Kuhn, KC Weisel
Clinical Lymphoma Myeloma & Leukemia 2012
Optimizing Treatment Strategies in Myeloma Cast Nephropathy: Rationale for a Randomized Prospective Trial
F Bridoux, JP Fermand
Advances in Chronic Kidney Disease 2012
The Pathogenesis of Acute Kidney Impairment in Patients With Multiple Myeloma
V Batuman
Advances in Chronic Kidney Disease 2012
Current Approach to Diagnosis and Management of Acute Renal Failure in Myeloma Patients
N Leung, J Behrens
Advances in Chronic Kidney Disease 2012
Myeloma Kidney: Improving Clinical Outcomes?
R Haynes, N Leung, R Kyle, CG Winearls
Advances in Chronic Kidney Disease 2012
Uremic Toxins: Niwa/Uremic Toxins
S Eloot, G Glorieux, PP de Deyn, R Vanholder
Uremic Toxins: Niwa/Uremic Toxins 2012
Casting out myeloma kidney
L Osherovich
Science-Business eXchange 2012
Myeloma kidney: advances in molecular mechanisms of acute kidney injury open novel therapeutic opportunities
A Davenport, G Merlini
Nephrology Dialysis Transplantation 2012
Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy
CA Hutchison, P Cockwell, M Cook
BMC clinical pathology 2012
Nephrology Secrets
S Hou
Nephrology Secrets 2012
The biology of immunoglobulin free light chains and kidney injury
K Basnayake, SJ Stringer, CA Hutchison, P Cockwell
Kidney International 2011
Online high-efficiency haemodiafiltration achieves higher serum free light chain removal than high-flux haemodialysis in multiple myeloma patients: Preliminary Quantitative Study
AG Vallee, L Chenine, H Leray-Moragues, L Patrier, C Cognot, G Cartron, JP Cristol, B Canaud
Nephrology Dialysis Transplantation 2011
Renal Disease in Hematological Malignancies
IS Abdul-Rahman
Hong Kong Journal of Nephrology 2011
High Cut-off Dialysis Membranes: Current Uses and Future Potential
B Gondouin, CA Hutchison
Advances in Chronic Kidney Disease 2011
Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: A single center experience
P Stratta, L Gravellone, T Cena, D Rossi, GL Gaidano, R Fenoglio, E Lazzarich, M Quaglia, A Airoldi, C Bozzola, G Monga, G Valente, C Canavese, C Magnani
Critical Reviews in Oncology/Hematology 2011
Extracorporeal Treatment of Cast Nephropathy
B Gakhar, S Kobrin, JS Berns
Seminars in Dialysis 2011
The pathogenesis and diagnosis of acute kidney injury in multiple myeloma
CA Hutchison, V Batuman, J Behrens, F Bridoux, C Sirac, A Dispenzieri, GA Herrera, H Lachmann, PW Sanders
Nature Reviews Nephrology 2011
Actualités dans le traitement du myélome avec insuffisance rénale
É Moumas, W Hanf, E Desport, J Abraham, S Delbès, C Debiais, L Lacotte-Thierry, G Touchard, A Jaccard, JP Fermand, F Bridoux
Néphrologie & Thérapeutique 2011
Pivotal role of apoptosis signal-regulating kinase 1 in monoclonal free light chain-mediated apoptosis
WZ Ying, PX Wang, PW Sanders
The American Journal of Pathology 2011
Multiple myeloma presenting as acute renal failure
VC Kuo, AZ Fenves, AN Mehta
Proceedings (Baylor University. Medical Center) 2011
Role of plasmapheresis in the management of myeloma kidney: A systematic review
D GUPTA, L BACHEGOWDA, G PHADKE, S BOREN, D JOHNSON, M MISRA
Hemodialysis International 2010
Management options for cast nephropathy in multiple myeloma
P Cockwell, CA Hutchison
Current Opinion in Nephrology and Hypertension 2010
Immunoglobulin Light Chains Activate Tubular Epithelial Cells through Redox Signaling
K Basnayake, WZ Ying, PX Wang, PW Sanders
Journal of the American Society of Nephrology : JASN 2010
Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis
CA Hutchison, AR Bradwell, M Cook, K Basnayake, S Basu, S Harding, J Hattersley, ND Evans, MJ Chappel, P Sampson, L Foggensteiner, D Adu, P Cockwell
Clinical journal of the American Society of Nephrology : CJASN 2009
Tamm-Horsfall protein protects the kidney from ischemic injury by decreasing inflammation and altering TLR4 expression
TM El-Achkar, XR Wu, M Rauchman, R McCracken, S Kiefer, PC Dagher
AJP Renal Physiology 2008
Approach to acute renal failure in biopsy proven myeloma cast nephropathy: Is there still a role for plasmapheresis?
L Pillon, RS Sweeting, A Arora, A Notkin, HS Ballard, RL Wieczorek, N Leung
Kidney International 2008
Pathogenesis and treatment of renal failure in multiple myeloma
MA Dimopoulos, E Kastritis, L Rosinol, J Bladé, H Ludwig
Leukemia 2008
A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia
P Gimsing, M Hansen, LM Knudsen, P Knoblauch, IJ Christensen, CE Ooi, P Buhl-Jensen
European Journal of Haematology 2008
Serum Free-Light Chain Removal by High Cutoff Hemodialysis: Optimizing Removal and Supportive Care
CA Hutchison, S Harding, G Mead, H Goehl, M Storr, A Bradwell, P Cockwell
Artificial Organs 2008
Effect of methionine oxidation on the structural properties, conformational stability, and aggregation of immunoglobulin light chain LEN
D Hu, Z Qin, B Xue, AL Fink, VN Uversky
Biochemistry 2008
Therapy in Nephrology & Hypertension
DH Ellison, CS Wilcox
Therapy in Nephrology & Hypertension 2008
Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease
CA Hutchison, S Harding, P Hewins, GP Mead, J Townsend, AR Bradwell, P Cockwell
Clinical journal of the American Society of Nephrology : CJASN 2008
Resolution of cast nephropathy following free light chain removal by haemodialysis in a patient with multiple myeloma: a case report
K Basnayake, C Hutchison, D Kamel, M Sheaff, N Ashman, M Cook, H Oakervee, A Bradwell, P Cockwell
Journal of medical case reports 2008
Obstructive Protein Cast Nephropathy in Cynomolgus Monkeys Treated with Small Organic Molecules
RE Guzman, K Datta, NK Khan
Veterinary pathology 2008
Myeloma Therapy
S Lonial
2008
Where disease pathogenesis meets protein formulation: Renal deposition of immunoglobulin aggregates
B Demeule, R Gurny, T Arvinte
European Journal of Pharmaceutics and Biopharmaceutics 2006
Dangerous small B-cell clones
G Merlini, MJ Stone
Blood 2006
A new twist in myeloma treatment
PW Sanders
Blood 2006
Management of paraproteinemic renal disease
PW Sanders
Current Opinion in Nephrology and Hypertension 2005
Management of paraproteinemic renal disease:
PW Sanders
Current Opinion in Nephrology and Hypertension 2005
Biology and Management of Multiple Myeloma
JR Berenson
2004
Tamm-Horsfall glycoprotein: biology and clinical relevance
F Serafini-Cessi, N Malagolini, D Cavallone
American Journal of Kidney Diseases 2003
Monoclonal Gammopathies and the Kidney
G Touchard, P Aucouturier, O Hermine, P Ronco
2003
Endocytosis of light chains induces cytokines through activation of NF-κB in human proximal tubule cells
S Sengul, C Zwizinski, EE Simon, A Kapasi, PC Singhal, V Batuman
Kidney International 2002
Urinary proteins and renal dysfunction in patients with multiple myeloma
A Corso, P Zappasodi, M Lazzarino
Biomedicine & Pharmacotherapy 2002
Mapping the Binding Domain of Immunoglobulin Light Chains for Tamm-Horsfall Protein
WZ Ying, PW Sanders
The American Journal of Pathology 2001
MALIGNANCY AND RENAL DISEASE
M Kapoor, GZ Chan
Critical Care Clinics 2001
Management of Renal Complications in Patients with Advanced Multiple Myeloma
A Viertel, E Weidmann, T Ditting, H Geiger
Leukemia & Lymphoma 2000
RENAL INVOLVEMENT IN MULTIPLE MYELOMA: A 10-YEAR STUDY
V Sakhuja, V Jha, S Varma, K Joshi, KL Gupta, K Sud, HS Kohli
Renal Failure 2000
Renal manifestations of plasma cell dyscrasias: An appraisal from the patients' bedside to the research laboratory
GA Herrera
Annals of Diagnostic Pathology 2000
Cytotoxicity of myeloma light chains in cultured human kidney proximal tubule cells
A Pote, C Zwizinski, EE Simon, S Meleg-Smith, V Batuman
American Journal of Kidney Diseases 2000
Bence Jones-Proteine. Bence Jones Proteins
F Boege
LaboratoriumsMedizin 1999
A middle-aged woman with refractory graft dysfunction in the early posttransplant period
X Geiger, D Harris, DV Buren, S Goral, JH Helderman, A Fogo
American Journal of Kidney Diseases 1999
Dietary salt regulates expression of Tamm-Horsfall glycoprotein in rats
WZ Ying, PW Sanders
Kidney International 1998
In vitro modulation of AL-amyloid formation by human mesangial cells exposed to amyloidogenic light chains
J Isaac, JD Kerby, WJ Russell, SC Dempsey, PW Sanders, GA Herrera
Amyloid 1998
Multiple Myeloma Presenting with Crystal Deposition in the Bone Marrow
SA Fadilah, SK Cheong
Hematology 1998
Critical Care Nephrology
C Ronco, R Bellomo
1998
Localization of a single binding site for immunoglobulin light chains on human Tamm-Horsfall glycoprotein
ZQ Huang, PW Sanders
Journal of Clinical Investigation 1997
Multiple Myeloma
R Bataille, JL Harousseau
New England Journal of Medicine 1997
BIOLOGY AND THERAPY OF IMMUNOGLOBULIN DEPOSITION DISEASES
MV Dhodapkar, G Merlini, A Solomon
Hematology/Oncology Clinics of North America 1997
Differential glycosylation of Bence Jones protein and kidney impairment in patients with plasma cell dyscrasia
T Kagimoto, H Nakakuma, H Hata, M Hidaka, K Horikawa, T Kawaguti, S Nagakura, N Iwamoto, K Shirono, F Kawano, K Takatsuki
Journal of Laboratory and Clinical Medicine 1997
The renal and hepatic distribution of Bence Jones proteins depends on glycosylation: a scintigraphic study in rats
MJ Prado, AL Nicastri, PL Costa, T Rockman, IL Tersariol, HB Nader, RT Barros, EB Prado
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... [et al.] 1997
Protein and host factors implicated in the pathogenesis of light chain amyloidosis (AL amyloidosis)
A Solomon, DT Weiss
Amyloid 1995
Acute myeloma kidney
CG Winearls
Kidney International 1995
Protease resistance and binding of Ig light chains in myeloma-associated tubulopathies
M Leboulleux, B Lelongt, B Mougenot, G Touchard, R Makdassi, A Rocca, LH Noel, PM Ronco, P Aucouturier
Kidney International 1995
Use of a renal tubule cell line (LLC-PK1) to study the nephrotoxic potential of a kappa-type bence-jones protein
MC Diemert, V Tricottet, L Benel, G Descamps, E Escolano, J Galli, M Reynès, F Rousselet
In vitro cellular & developmental biology. Animal 1995
Ultrastructural Immunolabeling: A Unique Diagnostic Tool in Monoclonal Light Chain-Related Renal Diseases
GA Herrera, PW Sanders, BV Reddy, JA Hasbargen, WS Hammond, JD Brooke
Ultrastructural Pathology 1994
Nephrotoxic Risks of Renal Angiography: Contrast MediaAssociated Nephrotoxicity and Atheroembolism—A Critical Review
MR Rudnick, JS Berns, RM Cohen, S Goldfarb
American Journal of Kidney Diseases 1994
Electrophoretic study of the physico-chemical characteristics of Bence-Jones proteinuria and its association with kidney damage
MC Diemert, L Musset, O Gaillard, S Escolano, A Baumelou, F Rousselet, J Galli
Journal of clinical pathology 1994
Bence Jones proteins bind to a common peptide segment of Tamm-Horsfall glycoprotein to promote heterotypic aggregation
ZQ Huang, KA Kirk, KG Connelly, PW Sanders
Journal of Clinical Investigation 1993
Tamm-Horsfall glycoprotein binds IgG with high affinity
DC Rhodes, EJ Hinsman, JA Rhodes
Kidney International 1993
Renale Verlaufsformen der Bence-Jones Proteinurie
F Boege, M Merkle, R Homeyer, F Gieseler
LaboratoriumsMedizin 1993
Systemic lambda light-chain deposition presenting with predominant cardiac involvement
MJ Garton, S Walton, SW Ewen
Postgraduate medical journal 1993
Mechanisms in B-Cell Neoplasia 1992
M Potter, F Melchers
1992
High-Resolution Electrophoresis and Immunofixation
DF Keren
High-Resolution Electrophoresis and Immunofixation 1987

← Previous 1 2 3 4 5 6 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 3 X users
Referenced in 2 patents
Referenced in 1 Wikipedia pages
65 readers on Mendeley
See more details